Mark Monterroso

Mark Monterroso practices at Watsonville Community Hospital in Watsonville, California, part of Pajaro Valley Health Care District.

Mark Monterroso's NPI, 1780119743, was assigned on April 27, 2017. Mark Monterroso graduated from Loma Linda University School Of Medicine in 2017. Mark Monterroso holds California license A158668.

Mark Monterroso's primary practice is Watsonville Community Hospital, at 75 Nielson Street, Watsonville, CA 95076 in Santa Cruz County. The practice phone is (831) 724-4741.

Mark Monterroso's primary practice is Watsonville Community Hospital in Watsonville, California, part of Pajaro Valley Health Care District. Mark Monterroso is also affiliated with Kaweah Health Medical Center. The medical group on file is Vituity. Dmand AI also links Mark Monterroso to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Monterroso practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Mark Monterroso's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Mark Monterroso is board certified in emergency medicine by the American Board of Emergency Medicine. Mark Monterroso is licensed in California.

CMS data shows 1,029 Medicare services from Mark Monterroso across 6 procedure codes in 2024, for 687 Medicare patients. Medicare paid $96,334 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 687 Medicare patients who saw Mark Monterroso in 2024. The largest group is 65 to 74, with 245 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 61% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Monterroso's median patient age at 32, with 55% women.

In 2024, Mark Monterroso wrote 333 Medicare Part D claims for 248 patients. 97% of them were for generic drugs. CMS names the drug for 229 of them, across 10 drugs with 11 or more claims each, at $1,428 in total drug cost. In 2023, CMS named 163 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Mark Monterroso for performance year 2024, reported as part of a group. Mark Monterroso accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 2 general payments to Mark Monterroso from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $28.

Mark Monterroso graduated from Loma Linda University School Of Medicine in 2017.

Mark Monterroso is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.